Perimeter Medical Imaging AI to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025
Financial Results Announcement: Perimeter Medical Imaging AI, Inc. will report its third quarter 2025 financial and operating results on November 12, 2025, followed by a webcast and conference call for discussion.
Company Overview: Perimeter is a medical technology company focused on transforming cancer surgery with advanced imaging tools, including the FDA-cleared Perimeter S-Series OCT system and the investigational Perimeter B-Series OCT with ImgAssist AI.
Regulatory Status: The Perimeter B-Series OCT is currently limited to investigational use in the U.S. and is not available for sale, while the S-Series OCT has received 510(k) clearance but has not been specifically evaluated for certain cancer-related uses.
Contact Information: For inquiries, the press release provides contact details for Stephen Kilmer (Investor Relations) and Adrian Mendes (CEO) along with their respective phone numbers and email addresses.
About the author









